Although TSPO PET is the most widely used biomarker to quantify in vivo central inflammation in patients with neurodegenerative diseases, its signal reflects TSPO overexpression in activated microglia cells and cannot fully capture the complexity of neuroinflammation in these conditions. The gene discussed is TSPO; the disease is neurodegenerative disease.